Cellares Announces Expanded Agreement with Bristol Myers Squibb to Include Second CAR-T Program in Cellares’ Technology Adoption Partnership Program

Contributed by: Business Wire

Logo

Tags

Biotechnology

Health

Pharmaceutical

Clinical Trials

Oncology

contract proof-of-concept manufacturing cell-therapy biopharmaceutical oncology biotech

More Like This

Cellares Expands Global Smart Factory Network With European Headquarters in the Netherlands

PR Newswire associated0

NueCell Bio Announces its Launch as a New Translational Partner for Cell Therapies with Unique Expertise to Accelerate Treatments from Discovery into GMP Manufacturing

SmartCella obtains approval for GMP manufacturing and quality control testing of cell therapies

PR Newswire associated0

Cellipont Bioservices and Adva Biotechnology Collaborate to Optimize Cell Therapy Manufacturing with the ADVA X3® Platform

PR Newswire associated0

Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development

PR Newswire associated0

Cellex Cell Professionals Surpasses 10,000 Autologous ATMP Manufacturing Batches

CCRM, OmniaBio and Avectas Partner to Improve Cell Therapy Manufacturing

Celltrio Secures $15 Million Financial Investment to Accelerate Global Expansion in Cell Culturing and Cell & Gene Therapy Automation